Mori Arkin (#2591)
- $ 2 B
- Pharmaceuticals
- Israel
- M
- 73 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company. The Arkins eventually moved into generic drug manufacturing, founding Agis Industries. In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock. Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 62%.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Mori Arkin’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Mori Arkin’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.5B
(May 4, 2026)
© Iconic Billionaires